Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

1.8%

1 terminated/withdrawn out of 55 trials

Success Rate

92.9%

+6.4% vs industry average

Late-Stage Pipeline

16%

9 trials in Phase 3/4

Results Transparency

0 of 13 completed trials have results

Key Signals

21 recruiting

Enrollment Performance

Analytics

Phase 2

14(37.8%)

N/A

12(32.4%)

Phase 4

7(18.9%)

Phase 3

2(5.4%)

Early Phase 1

1(2.7%)

Phase 1

1(2.7%)

37Total

Phase 2(14)

N/A(12)

Phase 4(7)

Phase 3(2)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (55)

Showing 20 of 55 trials

NCT07539792Phase 2Recruiting

Efficacy and Safety Evaluation of Absorbable and Moldable Skull Base Support Plates in Extended Endoscopic Endonasal Transsphenoidal Surgery: A Prospective, Randomized, Controlled Study

Role: collaborator

NCT05305859Phase 2Recruiting

Venetoclax Combining Chidamide and Azacitidine (VCA) in the Treatment of R/R AML

Role: collaborator

NCT04694495Completed

HPV Infection and Genital Microecology of Childbearing-age Female in China: A Cohort and Multicenter Study

Role: collaborator

NCT06904183Phase 2Recruiting

Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT

Role: collaborator

NCT06827899Phase 2Recruiting

Veneclax, Chidaniline Combined With Azacitidine Followed by Decitabine + MAG Regimen in the Treatment of Elderly Untreated AML

Role: collaborator

NCT06151106Phase 2Recruiting

Chidamide and Duvalisibon for the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma

Role: collaborator

NCT06158386Phase 2Recruiting

Chidamide Combined With Linperlisibon for the Treatment of Refractory/Relapsed Follicular Lymphoma

Role: collaborator

NCT05603884Phase 2Recruiting

VCA Regimen Followed by D-MAG Regimen on the Treatment of Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)

Role: collaborator

NCT06810791Phase 3Recruiting

HVA vs IA/DA or VA in the Treatment of ND HR-AML

Role: collaborator

NCT06763666Phase 4Not Yet Recruiting

CLAG+VEN vs CLAG in the Treatment of Relapsed/Refractory AML

Role: collaborator

NCT06201455Not ApplicableRecruiting

Evaluation of Phacogoniotomy in Medically-controlled POAG

Role: collaborator

NCT05892354Not ApplicableRecruiting

Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy

Role: collaborator

NCT06520176Phase 3Recruiting

Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients

Role: collaborator

NCT06512688Recruiting

Establishing Reference Ranges for Fat-Soluble Vitamins in Healthy Chinese Adults

Role: collaborator

NCT05291325Not ApplicableCompleted

Application of Linaclotide Capsule in Bowel Preparation for Colonoscopy

Role: collaborator

NCT03194945Phase 4Completed

Effects of Sequential Treatment Based on Lina/MET After Short-term Intensive Insulin in Newly Diagnosed Type 2 Diabetes

Role: collaborator

NCT06419283Early Phase 1Completed

Prospective Study on Safety and Efficacy of Stenting for Chronic Middle Cerebral Artery Occlusion With Limb Dysfunction

Role: lead

NCT06379243Not ApplicableRecruiting

Development and Validation of a Postoperative Re-fracture Risk Model for Osteoporotic Spinal Fractures

Role: collaborator

NCT06290817Phase 2Recruiting

Orelabrutinib Combined With R-CDOP for DLBCL Patients With High-risk of CNS Relapse Defined by CNS-IPI

Role: collaborator

NCT06035692Not ApplicableRecruiting

Application of Brachial Plexus Block in Patients Undergoing Cerebral Aneurysm Embolization Via Transradial Approach

Role: collaborator